AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Panalio 40 Injection

Prescription Icon
Prescription Required

Marketer

Amelio Pharmaceuticals

Salt Composition

Pantoprazole (40mg)

Overview Panalio 40 Injection

Acid-reducing injection, Gastrolin 40, lowers stomach acid production. It treats stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, easing symptoms and promoting healing. Gastrolin 40 is also used to prevent stress ulcers in critically ill patients and pre-anesthesia to reduce aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed more appropriate than oral medication. Dosage and treatment duration are determined by your condition and response, following your doctor's instructions even with rapid symptom improvement. Optimizing treatment involves frequent, smaller meals and avoiding caffeine, spicy, and fatty foods. Common, generally mild side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, stomach pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects require medical attention. Prolonged use (over a year) may increase bone fracture risk, particularly at higher doses; discuss bone loss prevention (e.g., calcium and vitamin D supplements) with your doctor. Gastrolin 40 is unsuitable for individuals with severe liver disease, those on HIV medications, those with a history of similar medication allergies, or pre-existing osteoporosis. Pregnant or breastfeeding individuals should seek medical advice before use. Alcohol should be avoided due to its acid-stimulating effects. Refrain from operating machinery if dizziness or drowsiness occurs.

Uses of Panalio 40 Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Panalio 40 Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Panalio 40 Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Panalio 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Panalio 40 Injection works:

Gastric acid secretion is diminished by Panalio 40 Injection, a proton pump inhibitor (PPI), thus alleviating heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Panalio 40 Injection is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Panalio 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administering Panalio 40 Injection while breastfeeding appears to pose minimal risk. Available human data indicates insignificant danger to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Panalio 40 Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Panalio 40 Injection poses no safety concerns for individuals with renal impairment; no alteration in dosage is necessary.

LiverLiverCAUTION

For individuals with severe hepatic impairment, Panalio 40 Injection requires careful administration. Dosage modification of Panalio 40 Injection might be necessary. Physician consultation is recommended.

What if you forget to take Panalio 40 Injection :

Omitting a scheduled Panalio 40 Injection necessitates contacting your physician.

Facts to Know About Panalio 40 Injection

LabelValue
Type of Compound Benzimidazole sulfoxide compound
Potential for Dependence None.
Medication Classification Gastrointestinal system
Mechanism of Action Gastric acid secretion suppressants

FAQs on Panalio 40 Injection

Panalio 40 Injection treats peptic ulcers, reflux esophagitis, and gastroesophageal reflux disease (GERD). This injection prevents acid buildup caused by pain relievers. Additionally, it's indicated for Zollinger-Ellison syndrome (ZES), a condition marked by excessive stomach acid. The medication achieves this by decreasing stomach acid production, thereby alleviating symptoms.
Concurrent use of antacids and Panalio 40 Injection is permissible, provided there's a two-hour interval between administrations.
Noticeable improvement should occur within 2–3 days. However, Panalio 40 Injection may require up to four weeks to achieve full effectiveness; some symptoms might persist until then.
Prolonged Panalio 40 Injection therapy may infrequently lead to increased body weight. This potential side effect might stem from improved reflux symptoms resulting in heightened food intake. Address any weight concerns with your physician.
Consuming alcohol while using Panalio 40 Injection is discouraged. While alcohol doesn't directly interfere with the injection's mechanism, it can elevate stomach acid levels, potentially exacerbating existing symptoms.
Administering Panalio 40 Injection one hour prior to eating is recommended. Dietary restrictions include spicy and fatty foods during treatment. Consumption of caffeinated beverages, including tea, coffee, and cola, should be ceased. Similarly, alcohol should be avoided to mitigate potential symptom exacerbation.
Panalio 40 Injection is typically recommended for brief treatment periods. Nevertheless, in specific cases like peptic ulcer disease or Zollinger-Ellison syndrome, prolonged administration may be necessary. Extended use increases the potential for adverse reactions and requires careful medical oversight. Always follow your physician's instructions and remain under their care when using Panalio 40 Injection.
Concurrent use of analgesics and Panalio 40 Injection is considered safe. Panalio 40 Injection offers protection against the gastrointestinal distress, including ulcers, that painkillers can cause. Panalio 40 Injection should be administered one hour prior to meals, while analgesics are typically best consumed with or following a meal to minimize stomach irritation.
A single dose of Panalio 40 Injection may prove inadequate. Relief from symptoms often occurs after just a few doses. Generally, Panalio 40 Injection is used briefly, up to two weeks, to manage heartburn, indigestion, and acid reflux. Nevertheless, longer-term use might be prescribed for conditions like peptic ulcer disease or Zollinger-Ellison syndrome. If symptoms persist after two weeks of regular use as directed, seek medical advice.
Extended Panalio 40 Injection use beyond three months can lead to adverse effects. Hypomagnesemia, a significant risk, may manifest as fatigue, confusion, dizziness, tremor, or muscle spasms, along with potential cardiac arrhythmias. Prolonged administration exceeding one year increases the risk of bone fragility, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can cause anemia, presenting as weakness, pallor, fatigue, palpitations, dyspnea, lightheadedness, digestive upset, anorexia, flatulence, or neurological symptoms including paresthesia and gait disturbances.
Panalio 40 Injection
36
MRP 44
18% off